The Archie & Irene Verspeeten Clinical Genome Centre
No two people are the same and genetic differences can mean that even if a treatment works for one patient, it may not work for another. Genomic profiling can help create personalized treatment to improve outcomes for patients with diseases linked to genetics such as cancer, epilepsy, neuromuscular disorders and developmental disabilities.
Tab 1
The First of its Kind in Canada
The Archie and Irene Verspeeten Clinical Genome Centre at London Health Sciences Centre (LHSC) will be the first of its kind in Canada and will result in state-of-the-art genetic diagnostics that will more accurately diagnose patients, predict the progress of their disease and provide highly targeted and new treatment options. The Verspeeten Clinical Genome Centre integrates the advanced translational research capabilities of a genome centre within the highly standardized and regulated clinical diagnostic laboratory environment.
"The Verspeeten Clinical Genome Centre will advance the standard of care by providing access to world-leading molecular genetic diagnostics and personalized medicine to cancer patients in southern Ontario. The centre will improve a patient's journey by uncovering unique information hidden in their personal genomes."
Dr. Bekim Sadikovic, Scientific and Clinical Director of the Verspeeten Clinical Genome Centre
The centre will provide the ability to potentially help transform fast-spreading and fatal cancers into manageable diseases through genomic profiling. The research and knowledge gained through this process will provide valuable information that will benefit patients now and, in the future.
The Archie and Irene Verspeeten Clinical Genome Centre will revolutionize treatment options for patients with diseases linked to genetics.
Archie and Irene Verspeeten have laid the ground work for the Verspeeten Clinical Genome Centre with their lead gift of $3 million but there is still more to do. The full vision for the Verspeeten Clinical Genome Centre is $10 million, which will provide patients access to in-depth genomic profiling, for improved patient outcomes. Your donation will help close the gap and have an impact on patients locally and has the potential to impact patients around the globe through research and knowledge sharing.